318 related articles for article (PubMed ID: 17028183)
1. Crystal structure of the Mycobacterium tuberculosis P450 CYP121-fluconazole complex reveals new azole drug-P450 binding mode.
Seward HE; Roujeinikova A; McLean KJ; Munro AW; Leys D
J Biol Chem; 2006 Dec; 281(51):39437-43. PubMed ID: 17028183
[TBL] [Abstract][Full Text] [Related]
2. How do azoles inhibit cytochrome P450 enzymes? A density functional study.
Balding PR; Porro CS; McLean KJ; Sutcliffe MJ; Maréchal JD; Munro AW; de Visser SP
J Phys Chem A; 2008 Dec; 112(50):12911-8. PubMed ID: 18563875
[TBL] [Abstract][Full Text] [Related]
3. Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.
McLean KJ; Carroll P; Lewis DG; Dunford AJ; Seward HE; Neeli R; Cheesman MR; Marsollier L; Douglas P; Smith WE; Rosenkrands I; Cole ST; Leys D; Parish T; Munro AW
J Biol Chem; 2008 Nov; 283(48):33406-16. PubMed ID: 18818197
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors.
Podust LM; Poulos TL; Waterman MR
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3068-73. PubMed ID: 11248033
[TBL] [Abstract][Full Text] [Related]
5. CYP121, CYP51 and associated redox systems in Mycobacterium tuberculosis: towards deconvoluting enzymology of P450 systems in a human pathogen.
McLean KJ; Dunford AJ; Sabri M; Neeli R; Girvan HM; Balding PR; Leys D; Seward HE; Marshall KR; Munro AW
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1178-82. PubMed ID: 17073780
[TBL] [Abstract][Full Text] [Related]
6. Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis.
Belin P; Le Du MH; Fielding A; Lequin O; Jacquet M; Charbonnier JB; Lecoq A; Thai R; Courçon M; Masson C; Dugave C; Genet R; Pernodet JL; Gondry M
Proc Natl Acad Sci U S A; 2009 May; 106(18):7426-31. PubMed ID: 19416919
[TBL] [Abstract][Full Text] [Related]
7. Probing Ligand Exchange in the P450 Enzyme CYP121 from Mycobacterium tuberculosis: Dynamic Equilibrium of the Distal Heme Ligand as a Function of pH and Temperature.
Fielding AJ; Dornevil K; Ma L; Davis I; Liu A
J Am Chem Soc; 2017 Dec; 139(48):17484-17499. PubMed ID: 29090577
[TBL] [Abstract][Full Text] [Related]
8. Structure-Function Analysis of the Essential
Padayachee T; Lamb DC; Nelson DR; Syed K
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732102
[TBL] [Abstract][Full Text] [Related]
9. Structural diversities of active site in clinical azole-bound forms between sterol 14alpha-demethylases (CYP51s) from human and Mycobacterium tuberculosis.
Matsuura K; Yoshioka S; Tosha T; Hori H; Ishimori K; Kitagawa T; Morishima I; Kagawa N; Waterman MR
J Biol Chem; 2005 Mar; 280(10):9088-96. PubMed ID: 15611056
[TBL] [Abstract][Full Text] [Related]
10. Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes.
McLean KJ; Marshall KR; Richmond A; Hunter IS; Fowler K; Kieser T; Gurcha SS; Besra GS; Munro AW
Microbiology (Reading); 2002 Oct; 148(Pt 10):2937-2949. PubMed ID: 12368427
[TBL] [Abstract][Full Text] [Related]
11. The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection.
McLean KJ; Lafite P; Levy C; Cheesman MR; Mast N; Pikuleva IA; Leys D; Munro AW
J Biol Chem; 2009 Dec; 284(51):35524-33. PubMed ID: 19846552
[TBL] [Abstract][Full Text] [Related]
12. Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06 A reveals novel features of cytochrome P450.
Leys D; Mowat CG; McLean KJ; Richmond A; Chapman SK; Walkinshaw MD; Munro AW
J Biol Chem; 2003 Feb; 278(7):5141-7. PubMed ID: 12435731
[TBL] [Abstract][Full Text] [Related]
13. Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1.
Chenge JT; Duyet LV; Swami S; McLean KJ; Kavanagh ME; Coyne AG; Rigby SE; Cheesman MR; Girvan HM; Levy CW; Rupp B; von Kries JP; Abell C; Leys D; Munro AW
J Biol Chem; 2017 Jan; 292(4):1310-1329. PubMed ID: 27932461
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium tuberculosis CYP130: crystal structure, biophysical characterization, and interactions with antifungal azole drugs.
Ouellet H; Podust LM; de Montellano PR
J Biol Chem; 2008 Feb; 283(8):5069-80. PubMed ID: 18089574
[TBL] [Abstract][Full Text] [Related]
15. Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs.
Jeffreys LN; Poddar H; Golovanova M; Levy CW; Girvan HM; McLean KJ; Voice MW; Leys D; Munro AW
Sci Rep; 2019 Feb; 9(1):1577. PubMed ID: 30733479
[TBL] [Abstract][Full Text] [Related]
16. Substrate and reaction specificity of Mycobacterium tuberculosis cytochrome P450 CYP121: insights from biochemical studies and crystal structures.
Fonvielle M; Le Du MH; Lequin O; Lecoq A; Jacquet M; Thai R; Dubois S; Grach G; Gondry M; Belin P
J Biol Chem; 2013 Jun; 288(24):17347-59. PubMed ID: 23620594
[TBL] [Abstract][Full Text] [Related]
17. A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals.
Ji H; Zhang W; Zhou Y; Zhang M; Zhu J; Song Y; Lü J
J Med Chem; 2000 Jun; 43(13):2493-505. PubMed ID: 10891108
[TBL] [Abstract][Full Text] [Related]
18. Rapid P450 heme iron reduction by laser photoexcitation of Mycobacterium tuberculosis CYP121 and CYP51B1. Analysis of CO complexation reactions and reversibility of the P450/P420 equilibrium.
Dunford AJ; McLean KJ; Sabri M; Seward HE; Heyes DJ; Scrutton NS; Munro AW
J Biol Chem; 2007 Aug; 282(34):24816-24. PubMed ID: 17553785
[TBL] [Abstract][Full Text] [Related]
19. The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention.
McLean KJ; Belcher J; Driscoll MD; Fernandez CC; Le Van D; Bui S; Golovanova M; Munro AW
Future Med Chem; 2010 Aug; 2(8):1339-53. PubMed ID: 21426022
[TBL] [Abstract][Full Text] [Related]
20. Structure-Activity Relationship and Mode-Of-Action Studies Highlight 1-(4-Biphenylylmethyl)-1H-imidazole-Derived Small Molecules as Potent CYP121 Inhibitors.
Walter I; Adam S; Gentilini MV; Kany AM; Brengel C; Thomann A; Sparwasser T; Köhnke J; Hartmann RW
ChemMedChem; 2021 Sep; 16(18):2786-2801. PubMed ID: 34010508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
